METRO | METRO HEALTHCARE BERHAD
0.205 (2.5%)
T-O (am): 0.000 (08:59:00)
Last updated: 16:50
METRO Fundamental Trend
FCON Ratio: Not enough data.
METRO Historical Dividends
METRO Financial Ratios
| EPS | 0.38 sen |
| Trailing PE (Sector Median: 23.9) | 53.7 |
| PEG | 0.54 |
| Altman Z | 0.0 |
| Beaver | 0 |
| Current Ratio | 0 |
| Debt-Equity (DE) Ratio | 0 |
| FCF Yield | 0.0 % |
| Revenue QoQ | -6.33 % |
| Revenue YoY | 0% |
| Profit QoQ | 163.88 % |
| Profit YoY | 0 % |
| Profit Margin (Sector Median: 7.5) | 7.65 % |
| ROE (ROIC: 0) | 0 % |
| Dividend Per Share (DPS) | 0.0 sen |
| Dividend Yield (DY) | 0.0 % |
METRO Adjusted Financial Ratios
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 23.9) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 7.5) | |
| ROE | |
| Altman Z |
METRO Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation | |
| Average Analysts FV based on 2 rating(s) |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 0.08 |
| Consistent QR FV |
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | 0.31 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 0 |
| Expected Revenue (M) | 0 |
| Expected Growth (%) | 0 |
METRO Directors Share Purchases (Beta)
No transaction in the last 2 months.
METRO Summary
Market Cap: 200 M.
Market Cap Class: Micro caps
Number of Shares: 978 M.
Adjusted Float: 0%.
Metro Healthcare Berhad is primarily focused on providing obstetrics and gynecological (O&G) healthcare services, with a specialization in fertility treatments. The company has strategically shifted its focus to enhance its core offerings in O&G healthcare, which include comprehensive fertility services and general obstetrics and gynecological care. To complement these services, Metro Healthcare also offers pediatric services; however, it has discontinued dental and traditional Chinese medicine fertility services as of 2022 and 2023, respectively. This realignment reflects the company’s commitment to strengthening its position within the O&G healthcare sector. Metro Healthcare was incorporated in 2010 and headquartered in Klang, Selangor, Malaysia.
Sectors: Healthcare, Health Care Providers, Penny Stocks
Code: 0329
Website: https://www.metro.com.my/
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
No warrants listed
METRO Top Shareholdings
| Shareholder | % | Value (M) |
|---|---|---|
| Dr Tay Swi Peng @ Tee Swi Peng | 43.47% | 87.22 |
| Lim Wai Khong | 0.78% | 1.57 |
| Seah Cheong Wei | 0.02% | 0.04 |
| Cik Rose Zilawati Binti Mohamed Arifin | 0.01% | 0.02 |
| Dr Yee Meng Kheong | 0.01% | 0.02 |
| Chua Leng Leek | 0.01% | 0.02 |